Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Abingdon Health PLC ( (GB:ABDX) ) has provided an update.
Abingdon Health PLC announced that it will release its preliminary results for the year ended 30 June 2025 on 11 November 2025. The company will host a live investor presentation on the same day, open to existing and potential shareholders. This announcement is part of Abingdon Health’s ongoing efforts to engage with stakeholders and provide transparency about its financial performance and strategic direction.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider, specializing in the development, manufacturing, and regulatory support for rapid diagnostic tests. The company offers comprehensive services, including lateral flow product development and technology transfer, catering to a global clientele in sectors such as infectious disease, clinical testing, animal health, and environmental testing. Founded in 2008, Abingdon Health is headquartered in York, England, with additional facilities in Doncaster, England, and Madison, Wisconsin, USA.
Average Trading Volume: 159,373
Technical Sentiment Signal: Sell
Current Market Cap: £15.11M
See more insights into ABDX stock on TipRanks’ Stock Analysis page.